Vesta Teleradiology | teleradiology

Radiology AI in 2026: From “Cool Tools” to Governance, Workflow & Quality

In 2026, the radiology AI conversation is shifting from “Which algorithm is best?” to “How do we run AI in production without creating new risks or new bottlenecks?” Hospitals and imaging leaders are under pressure to improve turnaround times, reduce backlogs, and keep quality consistent—yet everyone knows that technology layered onto an already complex workflow can backfire if it isn’t governed properly.

The most successful AI programs aren’t defined by a single tool. They’re defined by governance, interoperability, and measurable performance—and by a workflow design that supports radiologists rather than fragmenting their attention.

Why AI success looks different in 2026

Early AI adoption often focused on point solutions: a triage tool here, a detection aid there. Today, organizations want outcomes: faster reads, fewer misses, more consistent reporting, and fewer operational disruptions. That’s why governance is taking center stage. The American College of Radiology (ACR) has emphasized the need for formal AI governance and oversight structures to keep patient safety and reliability at the forefront.

At the same time, the industry is pushing hard on interoperability—making sure AI tools integrate into PACS/RIS and clinical communication rather than living in “yet another dashboard.” RSNA has showcased how workflow integration and standards can reduce friction points and help AI support real clinical scenarios.

The 2026 AI governance checklist (simple, practical, usable)

Whether you’re adopting your first tool or scaling across modalities, governance doesn’t need to be complicated—but it does need to be real. A strong governance model typically includes:

1) Clear clinical ownership

AI cannot be “owned by IT.” Radiology leaders should define:

Where AI is allowed to influence priority or interpretation
When radiologists can override AI outputs (and how overrides are documented)
What happens when AI and clinical suspicion conflict

2) Validation before scale

Before broad rollout, validate performance in your setting:

Scanner/protocol differences
Patient population differences
Volume and study mix differences

Even a great algorithm can underperform when protocols change or volumes surge.

3) Ongoing monitoring for drift

AI isn’t “install and forget.” Real-world performance changes over time—new scanners, new protocols, and shifting patient demographics can all cause drift. That’s why long-term monitoring is a growing focus in radiology AI standards efforts. For example, ACR has discussed practice parameters and programs aimed at integrating AI safely into clinical practice.

4) Operational metrics that matter

Track the metrics your hospital actually feels:

ED and inpatient turnaround time (TAT)
Backlog hours by modality
Discrepancy rates and peer-review signals
Percentage of cases escalated via triage
Radiologist interruption load (alerts, worklist reshuffles)

If AI improves one metric by harming another, it’s not a net win.

Where Vesta fits: AI + subspecialty reads + QA

For many hospitals, the most practical 2026 strategy isn’t “AI replaces humans.” It’s AI improves routing and prioritization, while subspecialty radiologists deliver the interpretation quality that clinical teams depend on.

A common best-practice workflow looks like this:

AI supports triage and worklist prioritization (especially for time-sensitive pathways)
Subspecialty radiologists provide consistent, high-confidence reads
QA processes (peer review, discrepancy tracking, feedback loops) ensure reliability over time

That combination is how you get the real goal: speed and confidence together—not speed at the expense of quality.

What to do next

If you’re building or refining an AI program in 2026, start with your workflow map—then add tools where they reduce friction. And make sure governance is designed before adoption accelerates.

If your team needs scalable subspecialty coverage to support operational goals (nights/weekends, overflow, or targeted service lines), Vesta Teleradiology can help you build a coverage model that keeps reads moving without sacrificing consistency. Learn more at https://vestarad.com.

2025 Year-End Review: The Radiology & Diagnostic Imaging Headlines That Mattered

Key Takeaways

AI shifted from pilot projects to real workflow infrastructure—with more focus on governance, validation, and safety in daily operations.

Photon-counting CT moved closer to mainstream adoption, strengthening the business case for next-gen CT planning and protocol upgrades.

Reimbursement and policy pressure stayed intense, keeping budgeting, contracting, and service-line ROI under a microscope.

Prior authorization and imaging appropriateness remained major throughput challenges, impacting scheduling, patient access, and operational efficiency.

Cybersecurity and downtime readiness became core imaging priorities, as ransomware and system disruptions increasingly threaten continuity of interpretation.

Radiology didn’t have a single “one story” year—it had a “many small shifts became operational reality” year. In 2025, diagnostic imaging leaders saw AI move from pilots into production workflows, next-gen CT mature from promise to procurement conversations, reimbursement pressures intensify, and cybersecurity become inseparable from patient care. Meanwhile, staffing strain and consolidation continued to reshape how coverage is delivered.

Below is a practical wrap-up of the biggest breakout themes from 2025—and what they signal for 2026 planning.

1) AI moved from point solutions to regulated, workflow-embedded infrastructure

If 2023–2024 was the era of “AI can detect X,” 2025 was the era of “AI has to behave safely inside real clinical systems.” Regulatory claritya and operational expectations became the story as much as the algorithms themselves. RSNA’s coverage highlighted how the FDA has been articulating pathways and challenges for AI-enabled radiology devices—making governance, validation, monitoring, and safety considerations a board-level topic, not just an R&D conversation. Daily Bulletin

At the same time, 2025’s conversation broadened from task-specific tools to foundation models and multimodal systems (images + text) that could impact triage, reporting support, and quality workflows—while also raising new risks around bias, generalizability, and clinical readiness. DirJournal

Operational takeaway for imaging leaders: AI value in 2025 increasingly depended on integration (PACS/RIS/reporting), change management, and clear accountability—especially as adoption expands and expectations shift from novelty to measurable outcomes. The Washington Post

2) Photon-counting CT stepped into the “real adoption” phase

Photon-counting CT (PCCT) wasn’t framed as a future curiosity this year—it showed up as a maturing platform with expanding clinical evidence and increasing operational readiness. RSNA 2025 coverage specifically called out how PCCT is taking center stage as the next CT evolution. Applied Radiology

Across 2025 literature and trade coverage, the narrative tightened around what administrators care about: clearer visualization and characterization, potential dose efficiencies, and broader specialty applications as the evidence base grows. ScienceDirect

Operational takeaway: If you’re building 3–5 year replacement plans, 2025 made PCCT a serious line item conversation—especially for high-volume sites where incremental image quality and protocol optimization can compound into throughput, repeat-scan reduction, and clinician confidence.

3) Payment pressure stayed relentless—and policy debates sharpened

For many departments, 2025 felt like a year of doing more with less. The 2025 Medicare Physician Fee Schedule (MPFS) final rule remained a major planning input for imaging groups and hospital finance teams, with ACR publishing a detailed imaging-focused summary of provisions and QPP updates. American College of Radiology

At the end of the year, broader Medicare payment policy debates also made headlines—reinforcing that specialty payment and “efficiency” assumptions are likely to stay politically active topics heading into 2026. Axios

Operational takeaway: Contracting, service line budgeting, and modality ROI assumptions increasingly need “policy sensitivity” built in—especially for outpatient imaging strategy and subspecialty coverage models.

4) Utilization management: prior auth and “right test, right patient” stayed in focus

Utilization controls continued to evolve. CMS prior authorization programs for certain outpatient services remain part of the broader backdrop of controlling unnecessary volume. CMS And late-2025 headlines underscored expanding demonstrations tied to prior authorization in additional settings, which imaging leaders often experience downstream as scheduling friction, referral leakage, or delayed care. Kiplinger

On the imaging appropriateness front, the Medicare AUC program remains a major framework (even as implementation timelines and mechanisms continue to be debated). CMS In 2025, ACR also publicly backed federal legislation (the ROOT Act) positioned as a way to revitalize Medicare imaging appropriateness workflows. American College of Radiology

Operational takeaway: Expect “appropriateness” and “utilization proof” to keep rising as operational requirements—meaning your radiology operation will benefit from tighter ordering communication loops, smarter triage, and documentation hygiene.

5) Breast imaging compliance stayed operationally important—density language included

Breast density notification requirements became routine compliance work after enforcement of MQSA’s amended regulations began in 2024, and 2025 was about living with the operational realities: consistent report language, patient communication workflows, and inspection readiness. U.S. Food and Drug Administration

Notably, 2025 also saw attention on density reporting language options under MQSA—an example of how “small wording changes” can have major downstream effects in templates, patient letters, and audit processes. DenseBreast-info, Inc.

Operational takeaway: Standardization wins here—clear templates, audit trails, and staff training reduce risk while improving patient communication consistency.

6) Workforce strain and burnout remained the constant—and coverage models kept shifting

Radiology’s capacity crunch persisted in 2025. ACR continued to flag ongoing workforce shortages amid rising imaging demand, while national physician burnout tracking suggested improvement from prior peaks but still elevated rates that affect retention and coverage reliability.

Operational takeaway: The “coverage plan” is now a strategic asset. Departments that treat coverage as a system (subspecialty access, peak-demand flex, nights/weekends/holidays, overflow protection, and consistent turnaround governance) are better positioned for 2026.

7) Cybersecurity became inseparable from imaging operations

Cyber risk is no longer “IT’s problem”—it’s a continuity-of-care risk, especially for imaging organizations that depend on always-on networks and data flow. In 2025, radiology-specific alerts and incidents reinforced how real the threat landscape is, from FBI-linked warnings about ransomware targeting healthcare entities to major breach reporting involving large imaging providers. Radiology Business

Operational takeaway: Imaging leaders should be asking: Do we have downtime playbooks? How resilient is PACS access? How are third-party integrations governed? How do we preserve interpretation continuity if local systems are disrupted?

A 2026-ready checklist for imaging leaders

Here’s what 2025’s headlines suggest you prioritize next:

AI governance that’s operational, not theoretical: validation, monitoring, and workflow accountability.
Modern CT strategy: map where photon-counting CT could change protocols, dose strategy, and long-term equipment planning. Applied Radiology
Payment + policy resilience: bake MPFS sensitivity into budgets and service line forecasts.
Utilization friction planning: anticipate prior-auth expansion impacts on scheduling and throughput.
Compliance consistency in breast imaging: templates, audits, and MQSA-ready workflows.
Coverage strategy as a system: subspecialty access + surge/overflow + nights/weekends/holidays planning.
Cyber continuity: imaging downtime workflows and vendor access governance.

Where Vesta Teleradiology fits in a “do more with less” reality

For hospitals and imaging centers, one of the most immediate ways to de-risk 2026 is to strengthen coverage—especially when staffing shortages collide with growing imaging demand. Vesta Teleradiology supports facilities with 24/7/365 coverage (including nights, weekends, and holidays) and subspecialty radiology interpretations designed to integrate with your existing technology and workflows.

If you’re planning for 2026 coverage resilience—overflow protection, consistent turnaround times, or expanded subspecialty reads—you can request a quote or schedule a test run here.

Breast Imaging 2025–26: Risk Models, CEM/MRI Momentum — RSNA Preview

RSNA 2025 is putting real energy behind risk-adjusted screening and the evolving roles of contrast-enhanced mammography (CEM) and breast MRI. For breast programs, the takeaway is practical: risk tools are moving from the research poster to the reading room, and CEM/MRI decisions are becoming operational levers you can plan around—especially for dense-breast pathways and overflow routing to subspecialists.

What’s new at RSNA: risk from the image itself

RSNA’s breast-imaging preview highlights sessions on image-only, 5-year breast cancer risk models, external validation work, and how MRI adds value in multi-modal AI. It also calls out global screening updates and a deeper look at background parenchymal enhancement (BPE) on MRI. RSNA

In parallel, the FDA granted De Novo authorization to the first image-only AI risk platform that predicts 5-year risk directly from a screening mammogram—an inflection point that makes risk-adjusted pathways far more scalable. Coverage from Radiology Business and BCRF explains the authorization and clinical intent. Radiology Business

Why it matters: average-risk guidance in the U.S. now begins screening at age 40 (USPSTF, 2024). Programs can layer image-based risk on top of that baseline to triage who needs annual vs. short-interval follow-up and who merits supplemental imaging. USPSTF

CEM is earning a seat next to MRI

Expect exhibits and sessions positioning CEM as a cost-effective, accessible adjunct—particularly for dense-breast populations and diagnostic workups. RSNA News recently framed CEM as a practical alternative to MRI in some screening/diagnostic scenarios, and new peer-review literature is refining technique (e.g., lower volume/higher-iodine contrast while preserving diagnostic performance). RSNA

On outcomes, the RACER trial in The Lancet Regional Health – Europe reported that using CEM as primary imaging for recalled women improved the accuracy and efficiency of the work-up compared with conventional imaging—evidence that will influence protocols beyond the show floor. The Lancet

MRI still leads for sensitivity—BPE is your underused signal

Breast MRI remains the sensitivity champion for high-risk patients and for problem solving. This year’s RSNA content spotlights BPE—how the level of background enhancement relates to tumor biology and outcomes. Recent reviews (2024–2025) synthesize BPE’s predictive/prognostic value, including associations with pathologic complete response after neoadjuvant therapy and survival in certain subtypes. SpringerLink

Practical move: standardize how you document BPE and incorporate it into structured reports and risk conferences; it’s becoming more than a descriptive footnote.

What to ask vendors at RSNA

Risk engine proof: “Show external validation and calibration plots by density and race; how does your image-only model integrate into our mammography worklist and letters?”
CEM logistics: “Demonstrate CEM acquisition workflows, contrast protocols, and how your viewer handles subtraction/kinetics alongside priors.”
MRI + BPE analytics: “Can we standardize BPE capture in structured reports and trend it across treatment?”

As risk-first screening, CEM, and MRI gain real traction, the winners will be the programs that operationalize them quickly and consistently. If you’re planning your 2026 breast-imaging playbook, stop by Vesta at RSNA to see how our subspecialists, standardized templates, and overflow routing make risk-adjusted pathways usable on day one.

Imaging the Individual — In the Trenches: AI, Personalization & Equity at RSNA 2025

RSNA’s 2025 theme, Imaging the Individual, isn’t just about futuristic science—it’s about doing the basics better for each patient, every day. The official Trending Topics preview highlights three threads cutting across subspecialties: AI you can deploy, personalized care you can operationalize, and equity you can measure. This guide translates those themes into practical checkpoints hospitals and imaging centers can use right now. RSNA

1) AI that graduates from pilot to practice

This year’s agenda emphasizes real outcomes over proofs of concept: reader-in-the-loop tools, bias monitoring, and governance. In breast imaging alone, RSNA previews spotlight external validation for image-only risk models and integration of MRI signals into multimodal AI—clear signals that “personalization” is landing in routine workflows. Bring vendor questions that force specifics: external validation cohorts, drift detection, and how metrics (TAT, recalls, rework) appear in your dashboard. RSNA

What to set up before RSNA: define 3–5 outcome metrics and insist every demo shows pre/post performance tied to those measures. Use QIBA concepts to push for standardized inputs/outputs so results are reproducible across scanners and sites. QIBA Wiki

2) Personalization that reaches the reading room

Personalization isn’t only radiogenomics. RSNA’s preview points to risk-stratified pathways you can actually run: e.g., image-only 5-year breast cancer risk at the point of screening to route patients into annual vs. short-interval follow-up or supplemental imaging (CEM/MRI). That pairs well with updated U.S. recommendations: screening beginning at age 40 for average-risk women, then adjusting based on risk and local policy. Build routing rules, templates, and letters now, so RSNA demos can plug into your plan.

Operational checklist:

Map risk thresholds → next steps (annual vs. short-interval, CEM/MRI).
Standardize templates so risk outputs appear consistently in reports and patient letters.
Decide who reviews outlier risk flags and how quickly (SLA).

3) Equity you can instrument—not just endorse

RSNA is foregrounding health equity, with sessions on encoding equity in AI and addressing access gaps for underserved communities. Equity becomes real when you can see it in your data: turnaround times by language, missed-appointment patterns by zip code, recall rates by screening site, and AI performance by subgroup. Build those slices into your analytics now; then ask vendors to show subgroup performance in their dashboards.

Practical moves:

Add demographic and language filters to your TAT and recall reports.
Require AI vendors to show calibration and error analysis by subgroup.
Stand up multilingual patient letter templates to support new screening starts at 40. USPSTF

4) CEM/MRI momentum: choose the lever that fits your service line

RSNA coverage calls out CEM as an increasingly practical adjunct—especially useful for dense-breast populations and diagnostic workups where capacity or cost limits MRI. The RACER trial reported higher accuracy and efficiency for CEM as the primary exam for recalled women vs. conventional imaging—evidence that can justify protocol changes and equipment planning. Meanwhile, MRI retains the sensitivity crown, with renewed attention on background parenchymal enhancement (BPE) as a signal worth documenting consistently.

Action items:

Decide where CEM fits: diagnostic recall pathway, dense-breast supplemental strategy, or both.
Add BPE level to structured MRI reports and trend it during therapy response clinics.

5) Governance, not guesswork

If personalization is the “what,” governance is the “how.” Use QIBA ideas—claim definitions, acquisition standards, and profile adherence—to control variability across devices and shifts. Tie RSNA learnings to a written governance plan with three parts: 1) protocol book (who owns it, update cadence), 2) quality book (metrics, subgroup views), and 3) AI book (approval process, monitoring, rollback).

6) Where teleradiology extends your capacity

Personalization increases complexity at peaks (recalls, dense-breast seasons, MR backlogs). A teleradiology partner helps you keep individualized pathways moving: standardized templates, subspecialty over-reads, and after-hours coverage that adheres to your risk rules and equity metrics—so “Imaging the Individual” doesn’t stop at 5 p.m.

Headed to RSNA?

Visit Vesta at Booth 1346 (South Hall) to see how we make “Imaging the Individual” work in real clinics—then enter to win a 1-year Medality CME subscription. Don’t wait: email “RSNA CME Entry” to info@vestarad.com now for a reserved entry, and show your confirmation at the booth for a bonus entry.

Powering Quality and Efficiency Through AI

Elevating Radiology. Expanding Access. Enhancing Care.

Vesta Teleradiology is redefining radiology delivery by integrating artificial intelligence (AI) into our diagnostic and operational workflows – helping hospitals of every size achieve higher quality, faster turnaround, and greater consistency in patient care.

Through our newly launched partnerships with Qure.ai and Carpl.ai, Vesta is bringing the benefits of AI assisted imaging to both large health systems and rural or underserved communities across the nation. This innovation enhances the speed, accuracy, and accessibility of radiology services – ensuring clinical excellence reaches every patient, everywhere.

AI Partnerships Driving Clinical Quality and Efficiency

Vesta now integrates Qure.ai’s FDA cleared AI solutions directly into our reading workflow to support both CT and X-ray imaging. For CT Brain (Non-Contrast), the AI automatically detects intracranial hemorrhages, fractures, and mass effect to improve triage and accelerate emergency response times. For Chest X-rays, it identifies nodules, effusions, and acute pulmonary findings to strengthen diagnostic consistency and enable earlier intervention. These tools work as a co-pilot for radiologists – helping prioritize critical studies, standardize interpretations, and deliver higher-quality reports with precision and speed.

Vesta also leverages Carpl.ai’s enterprise grade AI platform for musculoskeletal (MSK) fracture detection, enabling faster identification of subtle skeletal injuries that are often missed under high volume workloads. This integration enhances both radiologist efficiency and patient safety by improving consistency, turnaround times, and workflow throughput.

Expanding AI Across Vesta’s Clinical and Operational Ecosystem

In addition to our partnerships with Qure.ai and Carpl.ai, Vesta continues to implement AI across the organization to enhance both clinical quality and operational efficiency. Through RadPair, Vesta improves dictation accuracy, peer review workflows, and reporting analytics for radiologists – driving consistency and precision across the reading process.

On the operations side, Vesta has developed and launched an AI based support platform that allows staff to instantly retrieve internal protocols, radiologist schedules, credentialing data, and study specialty details from a centralized location. These tools streamline communication, improve turnaround time, and strengthen coordination across departments – supporting faster, more efficient service for clients and radiologists alike.

AI with a Purpose: Clinical Quality Care for All

Vesta’s mission has always been clear – to combine technology, compassion, and clinical excellence to improve access to quality radiology care. By implementing these AI partnerships and innovations, we’re ensuring faster turnaround for emergent and high acuity studies, improved diagnostic accuracy through validated AI support, greater access for rural and underserved hospitals, and consistent quality across every facility, 24/7/365.

These advancements reaffirm Vesta’s leadership as a trusted partner in AI driven radiology innovation, bringing cutting edge technology to the frontlines of patient care while optimizing the systems that support it.

About Vesta Teleradiology

Vesta Teleradiology is a Joint Commission-Accredited, 24/7/365 radiology provider serving hospitals, imaging centers, and healthcare systems nationwide. Our team of board-certified radiologists delivers timely, accurate, and secure interpretations – now further enhanced by AI technology to support faster decisions, higher quality, and better outcomes.

Interested in learning how Vesta’s AI powered radiology can support your hospital or health system?
Contact us at info@vestarad.com or visit www.vestarad.com/contact to schedule a demo or consultation.

Attribution:
Vesta Teleradiology integrates third party AI technologies through collaborations with Qure.ai, Carpl.ai, and RadPair. Descriptions of imaging and workflow capabilities in this publication are based on publicly available clinical use cases and are provided for informational purposes only. All content and messaging on this page are original to Vesta Teleradiology.

Vesta Teleradiology Heads to RSNA 2025: AI + Expertise = Faster, Smarter Imaging Coverage

Every year, the Radiological Society of North America (RSNA) brings together innovators shaping the future of medical imaging. This November 30–December 3, 2025, the Vesta Teleradiology team is proud to join that community at RSNA 2025 in Chicago — showcasing how AI and human expertise combine to deliver faster, smarter imaging coverage for hospitals and imaging centers nationwide.

Meet Vesta at Booth 1346 — South Hall

At Booth 1346, attendees can discover how Vesta helps healthcare facilities overcome some of today’s biggest radiology challenges — from staffing shortages to increasing imaging volumes — without compromising patient care.

Vesta’s solutions are designed to help your organization:

✅ Gain 24/7 radiology coverage without the burnout
✅ Access fellowship-trained subspecialists across all modalities
✅ Deliver faster turnaround times with AI-assisted workflow tools
✅ Scale imaging services without adding staff
✅ Rely on dependable IT services and seamless PACS integration

How Vesta Combines AI + Human Expertise

Teleradiology isn’t just about remote reads — it’s about precision, speed, and collaboration. Vesta’s radiologists use advanced AI-assisted workflow technology to prioritize cases, enhance diagnostic consistency, and streamline communication with hospitals and imaging centers.

AI tools don’t replace radiologists; they empower them. By automating repetitive tasks and highlighting critical findings faster, AI allows Vesta’s board-certified radiologists to focus where their expertise matters most — delivering accurate interpretations and improving patient outcomes around the clock.

Dependable Excellence, Every Time

Since its founding, Vesta has remained committed to providing dependable, high-quality radiology coverage that healthcare organizations can trust. Whether you need overnight support, overflow assistance, or full departmental coverage, Vesta’s network of U.S.-based, fellowship-trained subspecialists ensures that every scan gets the attention it deserves — anytime, anywhere.

View this post on Instagram

A post shared by Vesta Teleradiology (@vesta.teleradiology)

Join Us in Chicago

If you’re attending RSNA 2025, we’d love to meet you in person. Stop by Booth 1346 in the South Hall to see how Vesta’s combination of human insight and artificial intelligence is helping healthcare facilities achieve diagnostic excellence — without adding to their workload.

RSNA 2025 — Chicago, IL
November 30 – December 3, 2025
VESTARAD.COM

Vizamyl’s New PET Label: Quantify & Monitor Amyloid—What It Means for Imaging Teams

What changed—and why it matters

The FDA has expanded the label for flutemetamol F 18 (Vizamyl), enabling quantification of amyloid plaque burden and long-term therapy monitoring in Alzheimer’s disease. This shift moves amyloid PET beyond a qualitative “positive/negative” decision toward objective, longitudinal assessment that can inform treatment choice, dose intervals, and discontinuation decisions. Business Wire

Professional groups report the update aligns amyloid PET with the clinical era of disease-modifying anti-amyloid therapies (e.g., lecanemab, donanemab), clarifying roles for baseline confirmation, on-treatment monitoring, and response tracking in routine care. Notably, SNMMI stated the FDA granted supplemental indications—including quantitative measurement and use for therapy monitoring—to three amyloid PET agents (flutemetamol F-18/Vizamyl, florbetapir F-18, and florbetaben F-18). SNMMI

Operational updates for radiology leaders

Protocols & quant pipelines: Build or validate a quant workflow (SUVr or comparable metrics) that’s scanner-calibrated and reproducible across sites. If you operate multi-vendor fleets, document harmonization steps in your SOPs.
Structured reports: Add fields for quantified burden at baseline, change from baseline, and interpretive guidance tied to therapeutic decisions (initiation, continuation, or discontinuation).
Scheduling & throughput: Expect rising referral volume from neurology and geriatrics as therapy monitoring enters routine practice; protect access with extended hours or overflow capacity.
Quality & governance: Define thresholds for biologically meaningful change, reader training for quant review, and reconciliation rules when quant and visual impressions diverge.

For additional context, trade coverage underscores that the updated label formally removes previous limitations around therapy monitoring and permits quant analysis in routine reporting. Empr

How Vesta Teleradiology helps

Vesta’s subspecialty neuro and nuclear medicine radiologists provide:

Amyloid PET expertise: Visual+quant reads with structured templates aligned to your therapy pathway.
Coverage when you need it: After-hours, weekends, or daytime overflow—without sacrificing turnaround time.
Interoperability: Seamless delivery to your PACS/RIS and EMR; clear flags for therapy decisions and recall intervals.
QA you can see: Peer review, consistency checks across readers, and optional double-reads during program ramp-up.

If you’re standing up or scaling amyloid PET services, we can supply immediate subspecialty coverage and templates tuned to your neurologists’ needs.

FDA’s 2025 AI Draft Guidance: A Buyer’s Checklist for Imaging Leaders

In January 2025, the U.S. Food and Drug Administration released a draft guidance for AI-enabled medical devices that lays out expectations across the total product life cycle—design, validation, bias mitigation, transparency, documentation, and post-market performance monitoring. For imaging leaders, it’s a clear signal to tighten procurement criteria and operational guardrails before piloting AI in CT, MRI, mammo, ultrasound, or PET.

As teams lock in Q4 budgets and head into RSNA season, the FDA’s AI lifecycle draft (Jan 2025) and the now-final PCCP (Dec 2024) have reset what buyers should expect from AI in imaging—devices, software, and workflows. Vendors are updating claims and governance; this issue distills a practical buyer’s checklist—multisite validation with subgroup results, drift monitoring and version control, clear in-viewer transparency—and how pairing those tools with Vesta’s subspecialty coverage and QA turns promise into measurable gains across CT/MRI/US/mammography.

A practical buyer’s checklist

Use this when evaluating AI for your service lines:

Intended use fit: Verify indications, inputs/outputs, and claims match your pathway and patient mix.
Validation depth: Prefer multisite, diverse datasets; stratified results; pre-specified endpoints; documented data lineage and splits.
Bias mitigation: Demand subgroup performance (sex, age, race/ethnicity when available), scanner/vendor variability analyses, and site-transfer testing.
TPLC plan: Require drift monitoring, retraining triggers, versioning, and how updates are communicated.
Human factors & transparency: Ensure limitations, failure modes, and interpretable outputs are presented in-viewer without slowing reads.
Security & support: Patch cadence, vulnerability disclosure, SOC2/ISO posture, uptime SLAs, and rollback paths for version issues.
Governance: Define metrics owners, review cadence, and thresholds to pause or roll back a model.

Implementation playbook: pilot → scale without disruption

Start with a 60–90 day pilot in one high-impact line (e.g., ED stroke CT or mammography triage) and lock in baselines: median TAT, positive/negative agreement, recall rate, PPV/NPV, and discrepancy rate. Set guardrails—when to auto-triage vs. force human review—and document escalation paths for model failures. Require case-level confidence and structured outputs your radiologists can verify quickly. Stand up a model governance huddle (modality lead, QA, IT security, and your teleradiology partner) that meets biweekly to review drift signals, subgroup performance, and near-misses. Bake in a rollback plan (version pinning) and a quiet-hours change window so updates don’t collide with peak volumes. As results stabilize, scale by cohort (e.g., expand to non-contrast head CT, then CTA) and keep training “micro-bursts” for techs/readers—short videos or checklists in-workflow. Tie vendor SLAs to uptime, support response, and clinical KPIs so the AI program stays accountable to operational value.

Where teleradiology fits

AI only delivers when it’s welded to coverage, quality, and speed. A teleradiology partner should provide:

24/7 subspecialty + surge capacity: Vesta absorbs volume peaks so AI never becomes a bottleneck.
QA you can see: We benchmark pre/post-AI performance, add targeted second looks for edge cases, and feed variance data back to your team.
Standardized outputs: Structured reports that integrate model outputs with radiologist findings—no black-box surprises.
Smooth rollout: Pilot by service line (stroke CT, mammo triage, PE workups), then scale with tracked KPIs (TAT, PPV, recalls).
Interoperability & security: Seamless PACS/RIS/EMR integration with strict access controls, audit trails, and support for change-controlled updates.

Bottom line: Pairing AI with Vesta Teleradiology gives you round-the-clock subspecialty reads, measurable QA, and operational breathing room while you pilot and scale responsibly. If you’re mapping your AI roadmap under the FDA’s 2025 draft guidance, we’ll be your coverage and quality backbone—so your clinicians see faster answers and your patients see safer care. Visit vestarad.com to get started.

Summer 2025 Imaging Roundup: AI, New Modalities & Trends

The summer of 2025 has been packed with advancements in diagnostic imaging, from cutting-edge AI systems improving detection rates to emerging modalities pushing the boundaries of precision and speed. Here’s a look back at the most important developments from June through August that are shaping the future of radiology.

AI Is Reshaping Radiology Workflows

Generative AI Productivity Boost

In June, Northwestern Medicine unveiled a generative AI system capable of reducing radiologist reading time by up to 40% while identifying life-threatening conditions in milliseconds. This tool not only improves workflow efficiency but also offers a potential solution to the ongoing radiologist shortage (Northwestern Medicine).

ProFound AI for Mammography

A peer-reviewed study confirmed that iCAD’s ProFound AI significantly increases cancer detection rates, boosts diagnostic accuracy, and improves workflow for mammography screenings (ITN Online).

Aidoc’s $150M Expansion

July saw AI platform Aidoc raise $150 million in funding, led by NVIDIA and other major investors, aimed at expanding its reach into more hospitals and imaging centers globally (Aidoc).

Emerging Imaging Modalities and Research

Photon-Counting CT and Whole-Body MRI

Photon-counting CT continues to gain attention for its ability to deliver higher resolution at lower doses, while whole-body MRI is increasingly used for cancer staging and early detection in high-risk populations (Radiology Business).

Multimodality Imaging at ACC.25

Cardiologists and radiologists at the ACC.25 conference explored how quantitative CT, functional cardiac MRI, and AI-enhanced echocardiography can bridge the gap between diagnostics and real-time therapy planning (American College of Cardiology).

August: A Month of Imaging Breakthroughs

AI-Native Imaging Viewers

Tech company New Lantern launched AI-native viewer modes for mammography and PET/CT, delivering sub-second load times and workflow automation (TMCNet).

Digital Radiography Gets Smarter

Advances in digital radiography are enhancing precision and speed, with newer systems providing better image quality at lower radiation doses (USA News).

ProCUSNet Ultrasound AI

Researchers at Stanford developed ProCUSNet, an AI tool that improved lesion detection by 44% and caught 82% of clinically significant prostate cancers on ultrasound—outperforming human interpretation (Becker’s Hospital Review).

DiffUS for Intraoperative Imaging

A new AI-based technique called DiffUS can create realistic ultrasound images from 3D MRI data, aiding in surgical planning and intraoperative navigation (arXiv).

Next-Gen PET Tracer

A novel PET tracer, Ga-68 Trivehexin, has shown promise in more accurately detecting breast cancer lesions and fibrotic lung tissue compared to traditional tracers (Journal of Nuclear Medicine).

Looking Ahead

The pace of innovation in diagnostic imaging this summer reinforces a clear trend: AI is no longer just an assistive tool—it’s becoming deeply embedded in clinical workflows. Coupled with emerging modalities like photon-counting CT and new PET tracers, radiology is entering an era of higher precision, speed, and accessibility.

AI-Enabled Ultrasound: Transforming Imaging at the Point of Care

In today’s fast-paced healthcare environment, ultrasound is increasingly recognized not just for prenatal or cardiac assessment, but as a versatile diagnostic tool across specialties. Now, artificial intelligence (AI) is accelerating ultrasound’s impact — reducing operator dependency, improving diagnostic confidence, and enabling faster bedside care. For imaging leaders, especially in rural or underserved settings, AI-powered ultrasound technology paired with teleradiology support offers a compelling path for enhanced access and precision.

Innovations in AI-Ultrasound You Should Know

FDA Clearance for AI Thyroid Ultrasound
In 2024, See-Mode Technologies received FDA clearance for an AI-powered thyroid ultrasound system that can detect and classify nodules using the ACR TI-RADS scale. It has shown promising results in standardizing reporting and reducing unnecessary biopsies and follow-ups.
Source: https://www.auntminnie.com
Projected Market Growth
The global AI ultrasound market is projected to grow at a compound annual growth rate (CAGR) of 22% through 2029. This rapid growth is fueled by the rising burden of chronic disease, limited radiologist availability, and the push for faster, more accessible diagnostics.

Source: https://www.pharmiweb.com/
Rural Potential with Point-of-Care AI
A JAMA Cardiology viewpoint outlines how AI-assisted point-of-care ultrasound (POCUS) can enable more accurate cardiovascular assessments even when performed by generalists—especially valuable in remote areas without imaging specialists.
Source: https://jamanetwork.com
Clinician Enthusiasm and Challenges
The COMPASS-AI global survey found that 81% of clinicians support AI-assisted ultrasound, citing improved diagnostic utility and speed. However, top concerns include training, clinical validation, and workflow integration.

Source: https://theultrasoundjournal.springeropen.com/

Why It Matters for Facilities and Radiology Teams

Reduces staffing burden: AI ultrasound reduces variability among operators, ideal for high-turnover or remote settings.
Speeds up decision-making: Frontline providers can quickly gather meaningful imaging data, while teleradiologists handle the interpretation.
Expands imaging reach: Portable, AI-powered ultrasound extends diagnostic capabilities to underserved regions.
Supports standardization: AI helps standardize image acquisition and reporting, improving overall workflow efficiency.

How Vesta Teleradiology Enhances AI-Ultrasound Value

While AI augments imaging workflows, expert interpretation is still essential. Vesta provides:

Subspecialty reads across thyroid, vascular, MSK, and more
24/7 coverage with fast turnaround times
Seamless PACS/RIS integration for AI-acquired ultrasound data

Our radiologists help bridge the gap between frontline imaging and specialist analysis—ensuring that every AI-enabled ultrasound scan contributes to timely, confident patient care.

Bringing AI and Teleradiology Together

Whether you’re running a rural health center, a large outpatient clinic, or an emergency department, AI ultrasound paired with expert teleradiology interpretation helps:

Increase imaging access without compromising accuracy
Alleviate staffing constraints
Deliver faster diagnoses
Improve patient outcomes

AI in ultrasound is not replacing radiologists — it’s helping them focus on what matters most. With Vesta’s support, healthcare organizations can embrace innovation while maintaining high-quality, consistent imaging interpretation.